Stay updated with breaking news from Membrane Proteome Array. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this GEN webinar, our panelists will discuss their experiences using the MPA to rapidly identify potential off-target interactions, resulting in successful IND filings for CAR-T cell therapies where conventional approaches did not suffice.
In this GEN webinar, our panelists will discuss their experiences using the MPA to rapidly identify potential off-target interactions, resulting in successful IND filings for CAR-T cell therapies where conventional approaches did not suffice.
/PRNewswire/ -- Integral Molecular, the leader in antibody discovery against membrane proteins, has been accepted into the U.S. Food & Drug Administration...
LONDON (dpa-AFX) - Integral Molecular said that it reached an exclusive worldwide antibody license agreement with AstraZeneca (AZN, AZN.L) to develop therapeutics for multiple cancers.As per the
Integral Molecular Expands Partnership with Japan's Life Sciences Distributor Funakoshi to Provide Access to Antibody Specificity and Epitope Mapping Services - read this article along with other careers information, tips and advice on BioSpace